Last Updated on July 16, 2026 by The Health Master
Medical Device Industry
India’s New Medtech Push: Government Announces Up to ₹10 Crore Subsidy to Boost Medical Device Industry.
India is taking a massive leap into self-reliance in healthcare, and the Indian government is providing significant financial support for this initiative.
The Ministry of Chemicals and Fertilisers has opened applications for the Scheme for Strengthening of Medical Device Industry (SMDI), which offers a financial subsidy of up to ₹10 crore to domestic manufacturers of medical devices.
Two Sub-Schemes Under SMDI
The SMDI division of the Department of Pharmaceuticals has established two sub-schemes that will receive financial assistance on a reimbursement basis.
This means that the manufacturers will invest in the initiative first, and the government will reimburse them for the costs incurred.
Marginal Investment Scheme
The government will invest in the infrastructure of the medical device industry.
They will produce the essential components and raw materials required to produce these devices in India.
-
Target: Manufacturing of components, raw materials, devices, and accessories.
-
Goal: To minimize the importation of medical devices from foreign countries.
-
Financial Assistance: ₹10 crore.
Medical Device Clinical Studies Support Scheme
Any medical device concept cannot be brought to market without clinical trials to prove that the device is safe for human use.
The costs involved in clinical trials can be enormous, hence the creation of this sub-scheme.
Target: Funding for clinical and animal studies, clinical performance, and follow-up studies.
Goal: To show that the devices are safe and beneficial to patients when used as prescribed.
Financial Assistance: ₹5 crore.
Why the Government is Launching This Initiative
The Department of Pharmaceuticals is launching this initiative to increase the presence of Indian companies in the international medical devices market.
By lowering the barriers to entry for these manufacturers and innovators, the government hopes that more domestic companies will produce their essential medical devices to make healthcare for Indians more accessible and affordable.
Deadlines and How to Apply
There will be a significant amount of competition for the funds allocated to these schemes, so companies will need to act swiftly to apply.
Deadline: July 23, 2026, at 6:00 PM IST
How to Apply: Proposals can be submitted through the following link:
For more information on the schemes, visit the Department of Pharmaceuticals website:
Area required for manufacturing of Drugs, Cosmetics, Homoeopathic and Blood Centre
| Manufacturing area / section | Area prescribed for basic installations (Square Metre) | Ancillary Area prescribed (Square Metre) | Total Area required (Square Metre) |
| Allopathic drugs | |||
| External Preparations | 30 | 10 | 40 |
| Oral Liquid Preparations | 30 | 10 | 40 |
| Tablets (uncoated) Non-Beta Lactum (Granulation + compression + packaging etc) | 60 | 20 | 80 |
| Coating (Non-Beta Lactum) | 30 | 10 | 40 |
| Tablets (uncoated) Beta Lactum (Granulation + compression + packaging etc) | 60 | 20 | 80 |
| Coating (Beta Lactum) | 30 | 10 | 40 |
| Powders (oral) | 30 | – | 30 |
| Hard Gelatin Capsules (Beta-lactam) | 25 | 10 | 35 |
| Hard Gelatin Capsules (Non Beta-lactam) | 25 | 10 | 35 |
| Ophthalmic Preparation | 25 | 10 | 35 |
| Eye ointment, Eye lotion | 25 | – | 25 |
| Pessaries | 20 | – | 20 |
| Inhalers & Vitrallae | 20 | – | 20 |
| Re-packing of drugs | 30 | – | 30 |
| Parenteral (Small Volume Parenteral) | 150 | 100 | 250 |
| Parenteral (Large Volume Parenteral) | 150 | 150 | 300 |
| Plastic (LVP) by Form-Fill-Seal / Blow, Fill –Seal technology | 250 | 150 | 400 |
| Homoeopathic | |||
| Mother tincture and mother solutions | 55 | – | 55 |
| Potentization section | 20 | – | 20 |
| Trituration, Tableting, Pills and Globules section | 55 | – | 55 |
| Syrups & other oral liquids | 20 | – | 20 |
| Ointments & lotions section | 20 | – | 20 |
| Ophthalmic Preparations | 20 | – | 20 |
| Packing & labelling | 50 | – | 50 |
| Cosmetics | |||
| A. Powders | 15 | – | 15 |
| B. Skin powder for infants | 15 | – | 15 |
| C. Creams, Lotions, Shampoo, Shaving Creams, Hair Oils, Emulsions, Pastes, Cleansing Milk, Pomade | 25 | – | 25 |
| D. Nail Polish and Nail Lacquers | 15 | – | 15 |
| E. Lipsticks and Lipgloss | 15 | – | 15 |
| F. Depilatories used for eyes | 10 | – | 10 |
| G. 1. Eyebrows, Eyelashes, Eyeliners 2. Kajal and Surma | 10 10 | – 5 For base sterilization | 10 15 |
| H. Aerosols | 15 | – | 15 |
| I. Alcoholic Fragrance Solutions | 15 | – | 15 |
| J. Hair Dyes | 15 | – | 15 |
| K. Tooth powders general | 15 | – | 15 |
| L. Toilet Soaps | 100 | – | 100 |
| Blood Bank / Centre | |||
| Blood Bank / Centre (only for Whole Human Blood) | 100 | – | 100 |
| Blood Component | 50 | – | 50 |
| Blood Bank / Centre including Blood Components | 150 | – | 150 |
| Apheresis | 10 | – | 10 |
| Medical Devices |
| Area not prescribed in MDR 2017 for manufacturing of Medical Devices |
| Medicinal Gas |
| Area not prescribed for manufacturing of Medicinal gases |
| Disinfectant |
| Area not prescribed for manufacturing of Disinfectants |
| API (Bulk drug) |
| Area not prescribed for manufacturing of API (Bulk drugs) |
| Empty Capsule Shell |
| Area not prescribed for manufacturing of Empty gelatin Shell |
| Soft Gelatin Capsules |
| Area not prescribed for manufacturing of Soft Gelatin Capsules |
| Cytotoxic substances / Sex hormones |
| Same area required as defined for tablet section |
| Laboratory |
| Area for Commercial Laboratory or Laboratory for manufacturing units not prescribed |
Note: Requirement of ancillary area shall not apply to the units registered before 30-06-2005
Compiled by:
Lalit Kr. Goel, SDC, FDA Haryana
Rakesh Dahiya, ASDC, FDA Haryana
Download area requirement
Click below link to download the requirement for the manufacturing of Drugs, Cosmetics, Homoeopathic and Blood Centre
